Skip to content

The Impact of Tracheal Extubation Location After General Anesthesia on Perioperative Efficiency in Robot-Assisted Surgery: A Randomized Controlled Trial

The Impact of Tracheal Extubation Location After General Anesthesia on Perioperative Efficiency in Robot-Assisted Surgery: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114632
Enrollment
Unknown
Registered
2025-12-16
Start date
2025-12-16
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extubation site–related complications

Interventions

Intervention group (PACU extubation group):Following completion of surgery, patients were transferred to the PACU with the endotracheal tube in situ for recovery and subsequent extubation.
Control Group (Operating Room Extubation Group):Recovery and extubation in the operating room (OR), followed by routine monitoring in the post-anesthesia care unit (PACU).

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1)Age >= 18 years; (2)Scheduled to undergo elective robot-assisted laparoscopic surgery under general anesthesia; (3)Tracheal extubation feasible within the anesthesiologist’s daytime working hours (before 4:00 PM).

Exclusion criteria

Exclusion criteria: (1)Refusal to participate in the study; (2)Morbid obesity (body mass index >=35 kg/m²); (3)Preoperative diagnosis of obstructive sleep apnea, or patients with a STOP-Bang score >=3 in combination with serum bicarbonate (HCO3?) >= 28 mmol/L; (4)Patients identified during preoperative assessment as having a risk of difficult airway (anticipated difficult intubation and/or extubation); (5)Preexisting sick sinus syndrome, severe sinus bradycardia (heart rate = III; (6)Significant pulmonary function impairment (FEV1/FVC ratio = IV; (8)Preoperative diagnoses of schizophrenia, epilepsy, Parkinson’s disease, or myasthenia gravis; (9)Inability to communicate preoperatively due to coma, severe dementia, or language impairment; (10)Planned postoperative admission to the intensive care unit; (11)Any other condition deemed by the investigators or attending physicians to render the patient unsuitable for study participation.

Design outcomes

Primary

MeasureTime frame
Time from the end of surgery to discharge from the operating room;

Secondary

MeasureTime frame
Incidence of Emergence Delirium;Incidence of adverse events from the end of surgery to discharge from the PACU;Time from the end of surgery to achieving an Aldrete score of =9;Time from the end of surgery to discharge from the PACU;Time from the end of surgery to extubation;Interval between patient discharge and the entry of the subsequent patient (Room Turnover Time);Interval from the end of the current surgery to the start of the subsequent surgery;Quality of recovery on postoperative day 1 (POD 1), assessed using the QoR-15 scale;Length of hospital stay (LOS);Total hospitalization costs;Incidence of complications within 30 days after surgery;30-day all-cause mortality;

Countries

China

Contacts

Public ContactDing Ting

Peking University First Hospital

athena_d@sina.com+86 137 1880 3529

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026